Relay Therapeutics Inc. (RLAY)
4.00
-0.34 (-7.94%)
At close: Jan 15, 2025, 11:07 AM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Revenue | 25.55M | 1.38M | 3.03M | 82.65M | n/a | n/a |
| Cost of Revenue | 5.27M | 4.13M | 3.92M | 3.55M | 2.85M | 2.15M |
| Gross Profit | 20.28M | -2.75M | -896.00K | 79.11M | -2.85M | -2.15M |
| Operating Income | -373.00M | -299.27M | -364.70M | -55.80M | -84.05M | -49.89M |
| Interest Income | 31.05M | 8.79M | 830.00K | 3.40M | 8.80M | 1.11M |
| Pretax Income | -341.97M | -290.51M | -363.87M | -52.41M | -75.31M | -48.78M |
| Net Income | -341.97M | -254.26M | -496.81M | -49.01M | -66.50M | -48.78M |
| Selling & General & Admin | 74.95M | 65.98M | 57.39M | 38.59M | 13.74M | 8.86M |
| Research & Development | 330.02M | 246.35M | 172.65M | 99.86M | 70.31M | 41.03M |
| Other Expenses | n/a | -20.00K | -4.00K | -16.00K | -58.00K | -9.00K |
| Operating Expenses | 398.55M | 312.33M | 230.04M | 138.45M | 84.05M | 49.89M |
| Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 398.55M | 312.33M | 230.04M | 138.45M | 84.05M | 49.89M |
| Income Tax | n/a | -36.25M | 132.94M | -3.40M | -8.80M | 1.10M |
| Shares Outstanding (Basic) | 122.58M | 112.23M | 95.14M | 42.62M | 4.28M | 2.49M |
| Shares Outstanding (Diluted) | 122.58M | 112.23M | 95.14M | 42.62M | 4.28M | 2.49M |
| EPS (Basic) | -2.79 | -2.27 | -5.22 | -1.15 | -15.53 | -19.63 |
| EPS (Diluted) | -2.79 | -2.27 | -5.22 | -1.15 | -15.53 | -19.63 |
| EBITDA | -374.15M | -306.82M | -222.18M | -52.25M | -81.20M | -47.73M |
| Depreciation & Amortization | 5.27M | 4.13M | 3.92M | 3.55M | 2.85M | 2.15M |